Oxford Biomedica plc (OXB.L)
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
567.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+22.1%
The outlook
Oxford Biomedica plc currently reads as neutral based on strong buy — 1.4 avg of 8 analysts, below its 50- & 200-day averages, 27% of the way from its 52-week low to high, avg target +49% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 8 analysts
Price trendBelow its 50- & 200-day averages
52-week range27% of the way from its 52-week low to high
Price targetAvg target +49% vs current price
Analyst price target
~12-month · 8 analysts842.38average target+48.6% vs now
Now 567.00
Low 550.00High 1,140.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$686.3M
52-wk high
962.00
52-wk low
418.00
50-day avg
609.82
200-day avg
649.77
Trailing P/E
—